Bafna Pharmaceuticals Limited (BOM:532989)
132.50
-2.50 (-1.85%)
At close: Apr 22, 2026
Bafna Pharmaceuticals Revenue
Bafna Pharmaceuticals had revenue of 382.86M INR in the quarter ending December 31, 2025, with 15.36% growth. This brings the company's revenue in the last twelve months to 1.47B, down -0.51% year-over-year. In the fiscal year ending March 31, 2025, Bafna Pharmaceuticals had annual revenue of 1.46B, down -4.33%.
Revenue (ttm)
1.47B
Revenue Growth
-0.51%
P/S Ratio
2.19
Revenue / Employee
3.63M
Employees
406
Market Cap
3.23B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1.46B | -66.09M | -4.33% |
| Mar 31, 2024 | 1.52B | 371.16M | 32.18% |
| Mar 31, 2023 | 1.15B | 302.10M | 35.48% |
| Mar 31, 2022 | 851.40M | 139.22M | 19.55% |
| Mar 31, 2021 | 712.18M | 287.45M | 67.68% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| ZIM Laboratories | 3.78B |
| Albert David | 3.23B |
| Ambalal Sarabhai Enterprises | 2.03B |
| Medico Remedies | 1.91B |
| Everest Organics | 1.89B |
| Medicamen Biotech | 1.72B |
| Sat Kartar Life | 1.63B |
| Gennex Laboratories | 1.52B |